The New England Journal of Medicine 1996 Thomas C. Merigan - Abstracts
| The New England Journal of Medicine 1996 Thomas C. Merigan | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. | Health | Martin S. Hirsch, Scott M. Hammer, David A. Katzenstein, Robert T. Schooley, Michael M. Lederman, Michael D. Hughes, John P. Phair, Thomas C. Merigan, Holly Gundacker, Manette Niu, Richard H. Haubrich, W. Keith Henry | |||
| The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. | Health | Martin S. Hirsch, Scott M. Hammer, David A. Katzenstein, Susan Fiscus, Michael D. Hughes, J. Brooks Jackson, Thomas C. Merigan, Suraiya Rasheed, Holly Gundacker, Tarek Elbeik, Richard Reichman, Anthony Japour | |||
| Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. | Health | David A. Schoenfeld, Ann C. Collier, Lawrence Corey, Robert W. Coombs, Richard C. Reichman, Thomas C. Merigan, Vincent J. McAuliffe, Harvey M. Friedman, Roland L. Bassett, Timpone. Joseph, Alice Baruch, Michelle Jones, Karen Facey, Caroline Whitacre, Carol Hooper | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.